Annotated Medicine and Device Lists


Methyldopa

This medicine is present in:

List Section Observation
Colombia. "Listado de Medicamentos del Plan de Beneficios en Salud con Cargo a la UPC" 2016 Listado de Medicamentos del Plan de Beneficios en Salud con cargo a la UPC Others observations:
INCLUYE TODAS LAS CONCENTRACIONES Y FORMAS FARMACÉUTICAS
Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 02.03. FARMACOS ANTIHIPERTENSIVOS No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 12.3. Antihypertensive medicines Others observations:
Methyldopa is listed for use in the management of pregnancy-induced hypertension only. Its use in the treatment of essential hypertension is not recommended in view of the availability of more evidence of efficacy and safety of other medicines.
Peru 12.3 Anti-Hypertensives No observations
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Cvs Hypotensive Agents-Miscellaneous No observations
Costa Rica. Caja Costarricense de Seguro Social. 2019 08. Antihipertensivos No observations
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 1.4.2 Centrally Acting Alpha-Agonist No observations
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. Others observations:
X 50 TABLETAS
Mexico. Cuadro Basico de Medicamentos - 2017 03. CARDIOLOGIA No observations
Mexico. Cuadro Basico de Medicamentos - 2017 03. CARDIOLOGIA No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 C. APARELHO CARDIOVASCULAR No observations
Chile. Formulario Nacional de Medicamentos. 2005 11.03. ANTIHIPERTENSIVOS No observations
Guyana. Essential Medicines List. 2020-2021 15.02.01. Antiadrenergics- centrally acting- To be used in the Management of Pregnancy Induced Hypertension No observations
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 24:08 Anti-hypertensive agents No observations
Suriname. NGK-C-011 12.3 Antihypertensives No observations
Haiti. National List of Essential Medicines 12.03 Anti-hypertensives Others observations:
Only for treatment of pregnancy-induced hypertension
Barbados. Barbados National Drug Formulary (BNDF) 24.08.16 Central Alpha Antagonist No observations
Bahamas. Drug Formulary 02. CARDIOVASCULAR DRUGS No observations
Belize. National Drug Formulary 12.03 Antihypertensive medicines No observations
Cayman Islands Health Services Authority Pharmacy Drug Formulary 02.05.02 Centrally Acting Antihypertensive Drugs No observations

This medicine is present in:

List Section Observation
Costa Rica. Caja Costarricense de Seguro Social. 2019 08. Antihipertensivos No observations
Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020 02 ANTIHIPERTENSIVOS No observations
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 1.4.2 Centrally Acting Alpha-Agonist No observations
Paraguay. Lista de Medicamentos Esenciales. 2009 02. ANTIHIPERTENSIVOS No observations
El Salvador - 2019 ANTIHIPERTENSIVOS No observations
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 24:08 Anti-hypertensive agents No observations
Barbados. Barbados National Drug Formulary (BNDF) 24.08.16 Central Alpha Antagonist No observations
Bahamas. Drug Formulary 02. CARDIOVASCULAR DRUGS No observations
Cayman Islands Health Services Authority Pharmacy Drug Formulary 02.05.02 Centrally Acting Antihypertensive Drugs No observations

Information Resources: Methyldopa